Department of Clinical Research, University of Turku, Turku, Finland.
Department of Urology, Satasairaala Central Hospital, Wellbeing Services County of Satakunta, Pori, Finland.
Ann Med. 2023 Dec;55(1):1287-1294. doi: 10.1080/07853890.2023.2192046.
Transurethral resection of the prostate (TURP) is the standard surgical treatment for benign prostate enlargement (BPE). Photoselective vaporization of the prostate (PVP) is an alternative, but there is limited real-life evidence of PVP risks.
To compare short- and long-term risks of PVP to those of TURP in the treatment of BPE.
Consecutive patients who underwent elective PVP or TURP between 2006 and 2018 in 20 hospitals in Finland were retrospectively studied using a combination of national registries ( = 27,408; mean age 71 years). Short-term risks were postoperative mortality, major adverse cardiovascular events (MACE), and reoperations for bleeding. Long-term risks were reoperations for BPE or any urethral operations within 12 years. Differences between treatment groups were balanced by inverse probability of treatment weighting. Risks were analyzed using the Kaplan-Meier method and Cox regression.
There were no differences in postoperative mortality or MACE between the study groups. Reoperations for bleeding were less frequent after PVP (0.9%, HR: 0.72, = 0.042). Bleeding was more likely in patients with atrial fibrillation (number needed to treat [NNT] for PVP vs TURP: 61). Cumulative incidence for reoperation was higher after PVP (23.5%) than after TURP in long-term follow-up (17.8%; HR: 1.20, < 0.0001, NNT: -31.7).
PVP is associated with lower postoperative bleeding risk but higher long-term reoperation risk than TURP. Patients with high bleeding risk and a low likelihood of needing reoperation appear most suitable for laser vaporization.KEY MESSAGEPVP is associated with lower postoperative bleeding risk but higher long-term reoperation risk than TURP. PVP appears an attractive treatment option, especially for patients with high bleeding risk and a low likelihood of needing a reoperation.
经尿道前列腺切除术(TURP)是治疗良性前列腺增生(BPE)的标准手术治疗方法。前列腺激光汽化术(PVP)是一种替代方法,但关于 PVP 风险的实际证据有限。
比较 PVP 与 TURP 治疗 BPE 的短期和长期风险。
回顾性研究了 2006 年至 2018 年期间在芬兰 20 家医院接受选择性 PVP 或 TURP 的连续患者,使用国家登记处( = 27408;平均年龄 71 岁)进行组合。短期风险包括术后死亡率、主要不良心血管事件(MACE)和因出血再次手术。长期风险是指 12 年内因 BPE 或任何尿道手术再次手术。通过逆概率治疗加权法平衡治疗组之间的差异。使用 Kaplan-Meier 方法和 Cox 回归分析风险。
两组之间术后死亡率或 MACE 无差异。PVP 后因出血再次手术的频率较低(0.9%,HR:0.72, = 0.042)。心房颤动患者出血风险更高(PVP 与 TURP 相比,需要治疗的人数 [NNT]:61)。长期随访中,PVP 后再次手术的累积发生率(23.5%)高于 TURP(17.8%;HR:1.20, < 0.0001,NNT:-31.7)。
与 TURP 相比,PVP 术后出血风险较低,但长期再手术风险较高。高出血风险和低再手术可能性的患者似乎最适合激光汽化。关键信息:与 TURP 相比,PVP 术后出血风险较低,但长期再手术风险较高。PVP 似乎是一种有吸引力的治疗选择,尤其是对高出血风险和低再手术可能性的患者。